CONCLUSION: Opioid dependency, whether it results from the misuse or abuse of prescription or street drugs, continues to be a significant public health issue. Passage of DATA 2000 and US Food and Drug Administration approval of buprenorphine and buprenorphine/ naloxone has revolutionized opioid dependence therapy. The traditional addiction medicine therapy regimen of methadone maintenance, with its inherent legal limitations and restrictions, has been challenged by an office-based dependence practice with buprenorphine serving as a prominent therapeutic tool.
PMID: 22786460 [PubMed – in process] (Source: Pain Physician)
Office-based opioid dependence treatment.
Call 1 (888) 460-6556 to speak with a counselor.
